"Regtect" is a drug for the treatment of alcohol addiction, which affects the central nervous system and reduces the craving for alcohol.

Manufacturer: Nippon Shinyaku Co., Ltd. (Japan).

Active ingredient: acamprosate calcium.

Form of release: 100 tablets of 333 mg.

Method of use: Adults are recommended to take 2 tablets (666 mg of the active ingredient) 3 times a day after meals.

Contraindications: individual intolerance to the drugs, renal insufficiency, pregnancy and lactation, as well as simultaneous use of other medications.

Side effects: diarrhea, drowsiness, bloating, vomiting, skin rashes (eczema, psoriasis, hives), itching, and rashes.